TATYANA MANZIK: Open Payments
NPI 1902159643 · TONAWANDA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 40 payments from 17 companies in 2025. Trend: 2023 $1,389 · 2024 $917 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $151 |
| Dexcom, Inc. | 4 | $67 |
| Madrigal Pharmaceuticals | 2 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| PFIZER INC. | 2 | $52 |
| Exact Sciences Corporation | 3 | $47 |
| Abbott Laboratories | 2 | $45 |
| Lilly USA, LLC | 2 | $30 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: Wegovy, Dexcom G6 Transmitter, REZDIFFRA, DUPIXENT, FREESTYLE LIBRE 3, Ozempic, JARDIANCE, The Cologuard Plus Collection Kit.
Industry payments across NY — which companies pay providers there.
